Peptides for the New Millennium 2002
DOI: 10.1007/0-306-46881-6_183
|View full text |Cite
|
Sign up to set email alerts
|

Design of peptidomimetic farnesyltransferase inhibitors as anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2010
2010

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The approach facilitated the study of protein-protein interactions where multiple proteins are involved and demonstrated high-throughput monitoring of affinity-tagged proteins in expression and purification processes (Ro et al, 2005). Moreover, they chose the Human Papilloma Virus E6 protein with its binding proteins, the ligase E6AP and the tumor suppressor p53, as a model study to investigate the triple protein interaction (E6/E6AP/p53) that takes place during the viral A c c e p t e d M a n u s c r i p t infection (Ro et al, 2006). The complex formation induces a degradation of p53 and, consequently causes the transformation of normal cells into malignant cells and work in this area supports the development of new anticancer drugs against HPV-related cervical cancer.…”
Section: Shortly After Its Introduction Bymentioning
confidence: 99%
“…The approach facilitated the study of protein-protein interactions where multiple proteins are involved and demonstrated high-throughput monitoring of affinity-tagged proteins in expression and purification processes (Ro et al, 2005). Moreover, they chose the Human Papilloma Virus E6 protein with its binding proteins, the ligase E6AP and the tumor suppressor p53, as a model study to investigate the triple protein interaction (E6/E6AP/p53) that takes place during the viral A c c e p t e d M a n u s c r i p t infection (Ro et al, 2006). The complex formation induces a degradation of p53 and, consequently causes the transformation of normal cells into malignant cells and work in this area supports the development of new anticancer drugs against HPV-related cervical cancer.…”
Section: Shortly After Its Introduction Bymentioning
confidence: 99%
“…The approach facilitated the study of protein-protein interactions where multiple proteins are involved and demonstrated high-throughput monitoring of affinity-tagged proteins in expression and purification processes (Ro et al, 2005). Moreover, they chose the Human Papilloma Virus E6 protein with its binding proteins, the ligase E6AP and the tumor suppressor p53, as a model study to investigate the triple protein interaction (E6/E6AP/p53) that takes place during the viral infection (Ro et al, 2006). The complex formation induces a degradation of p53 and, consequently causes the transformation of normal cells into malignant cells and work in this area supports the development of new anticancer drugs against HPV-related cervical cancer.…”
Section: Accepted Manuscriptmentioning
confidence: 99%